ATE99681T1 - Cardiotonische alkanoyl- und aroyloxazole. - Google Patents

Cardiotonische alkanoyl- und aroyloxazole.

Info

Publication number
ATE99681T1
ATE99681T1 AT89102496T AT89102496T ATE99681T1 AT E99681 T1 ATE99681 T1 AT E99681T1 AT 89102496 T AT89102496 T AT 89102496T AT 89102496 T AT89102496 T AT 89102496T AT E99681 T1 ATE99681 T1 AT E99681T1
Authority
AT
Austria
Prior art keywords
alkanoyl
aroyloxazoles
cardiotonic
oxazolones
cardiotonics
Prior art date
Application number
AT89102496T
Other languages
English (en)
Inventor
Richard Schnettler
Richard C Dage
Winton D Jones
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE99681T1 publication Critical patent/ATE99681T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/38One oxygen atom attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT89102496T 1988-02-18 1989-02-14 Cardiotonische alkanoyl- und aroyloxazole. ATE99681T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/157,430 US4866182A (en) 1988-02-18 1988-02-18 Cardiotonic alkanoyl and aroyl oxazolones
EP89102496A EP0329070B1 (de) 1988-02-18 1989-02-14 Cardiotonische Alkanoyl- und Aroyloxazole

Publications (1)

Publication Number Publication Date
ATE99681T1 true ATE99681T1 (de) 1994-01-15

Family

ID=22563682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89102496T ATE99681T1 (de) 1988-02-18 1989-02-14 Cardiotonische alkanoyl- und aroyloxazole.

Country Status (19)

Country Link
US (1) US4866182A (de)
EP (1) EP0329070B1 (de)
JP (1) JP2811577B2 (de)
KR (1) KR960014794B1 (de)
CN (1) CN1022035C (de)
AT (1) ATE99681T1 (de)
AU (1) AU614029B2 (de)
CA (1) CA1334201C (de)
DE (1) DE68911944T2 (de)
DK (1) DK74889A (de)
ES (1) ES2061748T3 (de)
FI (1) FI890694A (de)
HU (1) HU206880B (de)
IL (1) IL89302A (de)
NO (1) NO890681L (de)
NZ (1) NZ227977A (de)
PH (1) PH26260A (de)
PT (1) PT89749B (de)
ZA (1) ZA891111B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5437491A (en) * 1994-04-07 1995-08-01 Illinois Tool Works Inc. Fuel door housing
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ES2125161B1 (es) 1996-03-21 1999-11-16 Grupo Farmaceutico Almirall S Nuevos derivados de 2-(3h)-oxazolona.
CN102993075A (zh) * 2012-11-29 2013-03-27 江苏长青农化股份有限公司 硫脲类杀虫杀螨剂丁醚脲的合成工艺
AU2016270903B2 (en) 2015-06-03 2020-04-30 Bristol-Myers Squibb Company 4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists for use in the treatment of cardiovascular disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514465A (en) * 1966-12-30 1970-05-26 Degussa Certain thiazolyl- and pyridinylaminoketones
US4303439A (en) * 1979-10-01 1981-12-01 Monsanto Company 2-Substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acids as safening agents
JPS59100977A (ja) * 1982-12-01 1984-06-11 Omron Tateisi Electronics Co 記録情報出力方法
DE3370170D1 (en) * 1982-12-18 1987-04-16 Rinninger Hans & Sohn Paving block
DE3246957A1 (de) * 1982-12-18 1984-06-20 Varta Batterie Ag, 3000 Hannover Galvanisches element
US4762849A (en) * 1985-10-15 1988-08-09 Merrell Dow Pharmaceuticals Inc. Cardiotonic alkanoylthiazolones
CA1266268A (en) * 1985-10-15 1990-02-27 J. Martin Grisar Cardiotonic aroylthiazolones
US4623651A (en) * 1985-10-15 1986-11-18 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4689353A (en) * 1986-02-21 1987-08-25 The Dow Chemical Company Hydroxy and amino-functional polyahls containing carbonate, urethane and/or urea moieties

Also Published As

Publication number Publication date
CN1022035C (zh) 1993-09-08
JP2811577B2 (ja) 1998-10-15
NO890681L (no) 1989-08-21
FI890694A0 (fi) 1989-02-14
DK74889A (da) 1989-08-19
DE68911944T2 (de) 1994-05-19
PH26260A (en) 1992-04-01
CA1334201C (en) 1995-01-31
AU2990689A (en) 1989-08-24
DK74889D0 (da) 1989-02-17
AU614029B2 (en) 1991-08-15
CN1036761A (zh) 1989-11-01
ES2061748T3 (es) 1994-12-16
EP0329070B1 (de) 1994-01-05
PT89749A (pt) 1989-10-04
HUT54148A (en) 1991-01-28
PT89749B (pt) 1994-03-31
NO890681D0 (no) 1989-02-17
KR890012983A (ko) 1989-09-20
NZ227977A (en) 1990-10-26
IL89302A0 (en) 1989-09-10
US4866182A (en) 1989-09-12
HU206880B (en) 1993-01-28
JPH02149571A (ja) 1990-06-08
DE68911944D1 (de) 1994-02-17
ZA891111B (en) 1989-10-25
EP0329070A1 (de) 1989-08-23
IL89302A (en) 1993-02-21
FI890694A (fi) 1989-08-19
KR960014794B1 (en) 1996-10-19

Similar Documents

Publication Publication Date Title
DE3586863D1 (de) Verstaerker mit eingangsfaehigkeit ueber den gesamten versorgungsspannungsbereich und geregelter transkonduktanz.
DE69110937D1 (de) Herzschrittmacher zur Beendung von Herzarrhythmia.
FI864597A0 (fi) Kardiotoniska tiazoloner.
ATE99681T1 (de) Cardiotonische alkanoyl- und aroyloxazole.
ES2000594A6 (es) Un procedimiento para la preparacion de tiazolonas
DE69012298D1 (de) Heizen von Lagern und dergleichen.
DE3686472T2 (de) Cardiotonische phenyloxazolone.
DE3676632D1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
CA1266268C (en) CARDIOTONIC AROYLTHIAZOLONES
DE3872981D1 (de) Phenylthioharnstoffe, -isothioharnstoffe und -carbodiimide, ihre herstellung und verwendung bei der kontrolle von schaedlingen.
DE3882545D1 (de) Verwendung von trifluormethansulfonamid gegen glaukom.
DE284084T1 (de) Stark suesse l-aspartyl-3-(bicycloalkyl)-l-alaninalkylester.
DE68920803T2 (de) Stabilisierung und Verringerung der Hintergrund-Fluoreszenz von Hydroxy-cumarin-ester Enzymsubstraten.
ATE94166T1 (de) Zusammensetzung auf der basis von cyclopolygalakturonsaeure und verwendung derselben.
NO870591D0 (no) Laasutloesningsmekanisme med elektromagnet med relestyrt stroemforsyning.
ATE59385T1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties